SOC 2 Audits for Clinical Trial Software Companies
Sponsors and CROs evaluate eClinical platforms against 21 CFR Part 11 and GxP before trusting them with trial data. Here is how clinical trial software companies scope SOC 2 as the security backbone underneath validation — Part 11 adjacency, blinded-data confidentiality, and cost.
Why clinical trial software companies get asked for SOC 2
Clinical trial software — EDC, eCOA and ePRO, CTMS, eConsent, and the platforms behind decentralized trials — sells into pharmaceutical and biotech sponsors, contract research organizations (CROs), and academic research sites. Their quality and vendor-risk teams evaluate you against Good Clinical Practice (GCP) expectations and 21 CFR Part 11 for electronic records and signatures, and a SOC 2 Type 2 is the security backbone they expect underneath a computer system validation (CSV) effort.
The data at stake is trial data governed by GCP: subject records and ePRO responses, randomization and blinding assignments, adverse-event reports, and the audit trails regulators can inspect. Sponsors and CROs care intensely about data integrity — the ALCOA principles that records be attributable, legible, contemporaneous, original, and accurate — and about keeping blinded data confidential so a study's integrity holds. Reviewers probe audit trails, access controls, and change management far more deeply than a typical SaaS buyer. SOC 2 complements Part 11 and GxP validation; it does not replace them.
Trust Services Criteria focus for Clinical Trial Software
Security (the Common Criteria) is mandatory in every SOC 2 report. The other four criteria are elective — you scope them in based on what your customers actually rely on. Here is how clinical trial software companies typically scope them, and why:
| Criterion | Typical scope | Why it matters in Clinical Trial Software |
|---|---|---|
| Security | Always in scope | Mandatory in every SOC 2. For clinical trial software, expect focus on access control to trial records, protection of blinding and randomization data, and change control over validated environments. |
| Availability | Common | Active studies and enrollment windows depend on your uptime; sponsors want tested backups and recovery for subject data and audit trails that cannot be reconstructed if lost. |
| Confidentiality | Usually in scope | Blinded assignments, subject data, and sponsor protocols are confidential by contract. Reviewers expect strong tenant isolation between sponsors and controls that keep blinded data from reaching unblinded roles. |
| Processing Integrity | Common | Central to this category: when EDC and ePRO records feed regulatory submissions, buyers want evidence of validation, completeness, edit checks, and controlled data changes across the trial. |
| Privacy | Sometimes | Scoped in when platforms hold identifiable subject data or run direct-to-participant workflows; studies working with coded or de-identified data often address it through Confidentiality instead. |
Each elective criterion adds controls and evidence — and cost. Scope what your customers demand in security reviews, not everything at once.
Scoping decisions specific to Clinical Trial Software
These are the Clinical Trial Software-specific calls that shape your system description, control list, and ultimately your audit price. Settle them before you request quotes — firms price scope, not industry labels.
Draw the GxP vs non-GxP boundary
Separate systems that hold regulated trial records subject to 21 CFR Part 11 from sandbox, training, and analytics environments. The audited boundary and the depth of change control differ sharply, and conflating them balloons scope; be explicit about which environments carry validated status.
Part 11 audit trails and electronic signatures
For regulated records, reviewers expect tamper-evident audit trails and controlled electronic signatures. Auditors sample whether audit trails are enabled by default, protected from edits, and retained for the required record lifetime — because inspectors can request them.
Blinded-data confidentiality and role separation
A trial's integrity depends on unblinded users never reaching blinded assignments. Demonstrate role separation, access controls, and per-sponsor tenant isolation so randomization and blinding data cannot leak between roles or between studies.
Data integrity across EDC and ePRO (ALCOA)
Trial data passes through capture, edit checks, and query resolution. Show controls that keep records attributable and accurate — versioned changes, query management, and controlled corrections rather than silent overwrites of prior entries.
Computer system validation handoff
Sponsors and CROs running CSV rely on your change and release controls as inputs to their validated state. Document how you communicate changes to validated environments so customers can maintain validation without being surprised by an update.
What a SOC 2 audit costs for clinical trial software companies
These are first-party published rates from accredited firms on the AuditNex network — actual prices, not survey estimates. Data as of 2026-07-26.
Quote requests priced at network rates: Withheld — 2 samples, below our 5-sample minimum.
Frameworks clinical trial software companies pair with SOC 2
SOC 2 is rarely the only requirement in this category. These are the frameworks most often pursued alongside it — and overlapping evidence you can reuse if you plan both from the start:
| Framework | Why it comes up alongside SOC 2 |
|---|---|
| 21 CFR Part 11 | The FDA rule for electronic records and signatures in regulated trials. SOC 2 access, audit-trail, and change controls provide much of the evidence base, but Part 11 compliance is a customer-and-system-specific determination, not something SOC 2 grants. |
| GxP / computer system validation | Sponsors and CROs must validate the systems they use in a trial. Your SOC 2 controls feed their CSV effort as supplier evidence, though the validation itself remains their responsibility. |
| ISO 27001 | Global pharma sponsors frequently prefer certification. The ISMS overlaps substantially with SOC 2 Security, so both can run on one evidence base when you sell internationally. |
Finding an auditor who knows Clinical Trial Software
Best SOC 2 auditors for healthcare › · All auditor profiles › · How we verify auditors ›
SOC 2 for Clinical Trial Software: common questions
Does SOC 2 satisfy 21 CFR Part 11 for our platform?
No. SOC 2 provides the security foundation — access control, audit trails, and change management — that Part 11 and computer system validation build on. It supports your customers' validation efforts as supplier evidence, but Part 11 compliance and CSV remain determinations they make about their own use of your system.
How do we protect blinded data in a SOC 2?
By demonstrating role separation and access controls that keep unblinded users away from randomization and blinding assignments, plus tenant isolation between sponsors. Auditors sampling Confidentiality will test these boundaries directly, so document the model before the observation window opens.
Should we scope Processing Integrity for an EDC or ePRO platform?
Often yes. When customers rely on your platform to capture data that feeds regulatory submissions, Processing Integrity tests validation, edit checks, completeness, and controlled changes across the trial. If your product only stores and shares data without capturing or transforming it, Security and Confidentiality may be sufficient.
Why do sponsors and CROs care so much about data integrity?
Because trial results and submissions depend on records being trustworthy under the ALCOA principles, and regulators can inspect the audit trail. Reviewers probe whether audit trails are tamper-evident, whether data can be silently overwritten, and how corrections are controlled — far more deeply than a typical SaaS buyer.
Get SOC 2 quotes scoped for Clinical Trial Software
Answer five questions once — we’ll show accredited auditors that fit your scope, with transparent pricing and no sales calls. Scope it the way this guide describes: report type, criteria mix, and timeline are what drive your quotes.
Start a quote →